Další formáty:
BibTeX
LaTeX
RIS
@article{1730584, author = {Folta, Adam and Jurcek, Tomas and Kubesova, Blanka and Žáčková, Daniela and Semerád, Lukáš and Mayer, Jiří and Ježíšková, Ivana}, article_location = {LONDON}, article_number = {5}, doi = {http://dx.doi.org/10.1080/10428194.2020.1861274}, keywords = {CE-IVD tests; BCR-ABL1 transcript monitoring; chronic myeloid leukemia}, language = {eng}, issn = {1042-8194}, journal = {LEUKEMIA & LYMPHOMA}, title = {Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients}, url = {https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1861274}, volume = {62}, year = {2021} }
TY - JOUR ID - 1730584 AU - Folta, Adam - Jurcek, Tomas - Kubesova, Blanka - Žáčková, Daniela - Semerád, Lukáš - Mayer, Jiří - Ježíšková, Ivana PY - 2021 TI - Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients JF - LEUKEMIA & LYMPHOMA VL - 62 IS - 5 SP - 1239-1242 EP - 1239-1242 PB - INFORMA HEALTHCARE SN - 10428194 KW - CE-IVD tests KW - BCR-ABL1 transcript monitoring KW - chronic myeloid leukemia UR - https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1861274 L2 - https://www.tandfonline.com/doi/full/10.1080/10428194.2020.1861274 N2 - According to European Leukemia Network (ELN) recommendations, real-time quantitative PCR (qRT-PCR) is a conventional strategy for long-term BCR-ABL1 transcript monitoring in patients with chronic myeloid leukemia (CML) both during tyrosine kinase inhibitor (TKI) therapy and its discontinuation [1–5]. However, with the new Regulation (EU) 2017/746 coming, health institutions will have to start using CE-marked IVD (CE-IVD) devices (including kits, reagents, calibrators, etc.) for analyses. Thus, commercial CE-IVD tests will also enter into routine CML diagnostics in the near future. ER -
FOLTA, Adam, Tomas JURCEK, Blanka KUBESOVA, Daniela ŽÁČKOVÁ, Lukáš SEMERÁD, Jiří MAYER a Ivana JEŽÍŠKOVÁ. Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients. \textit{LEUKEMIA \&{} LYMPHOMA}. LONDON: INFORMA HEALTHCARE, 2021, roč.~62, č.~5, s.~1239-1242. ISSN~1042-8194. Dostupné z: https://dx.doi.org/10.1080/10428194.2020.1861274.
|